Ambu ASWBO:AMBU +0.28%63 Buyback Yield % is 0.86 as of Jul. 04, 2026. GuruFocus rates WBO:AMBU with a GF Score™ of 63/100 and a GF Value™ of €17.17 (Significantly Undervalued). Among 347 Medical Devices & Instruments companies, Ambu AS ranks better than 78.1% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Ambu AS's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:AMBU vs ABT, SYK, MDT: Buyback Yield % Comparison
For the Medical Devices subindustry, Ambu AS's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambu AS Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ambu AS's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Ambu AS's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ambu AS (WBO:AMBU) has a Buyback Yield % of 0.86 as of Jul. 04, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Ambu AS and its competitors. According to the industry distribution chart, Ambu AS ranks #76 out of 347 companies in the Medical Devices & Instruments industry, placing it in the top 21.9%.
Is Ambu AS's Buyback Yield % too high?
Ambu AS's current Buyback Yield % is 0.86. Based on the distribution chart, Ambu AS ranks #76 out of 347 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Ambu AS has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ambu AS ranks #76 out of 347 companies for Buyback Yield %. This places Ambu AS in the top 22% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Ambu AS and its competitors. Ambu AS's current Buyback Yield % is 0.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Based on GuruFocus' analysis, Ambu AS (WBO:AMBU) is currently considered Significantly Undervalued. The stock's GF Value™ is €17.17, compared to a current price of €8.90 — trading 48.2% below its estimated fair value. The current Buyback Yield % is 0.86. Ambu AS's overall GF Score™ is 63/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Ambu AS (WBO:AMBU), the current Buyback Yield % is 0.86 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambu AS (WBO:AMBU) Overvalued in 2026?
Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued.
The current stock price of €8.90 is trading 48.2% below its estimated GF Value™ of €17.17.
GuruFocus considers Ambu AS to be Significantly Undervalued.
Key valuation signals for WBO:AMBU:
Buyback Yield %: 0.86
GF Value™: €17.17 vs. price of €8.90 (48.2% below fair value)
No single metric tells the full story. See the WBO:AMBU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
63GF Score
Get the complete analysis for WBO:AMBU
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:AMBU has been successfully added to your 
